Patients with glioblastoma, an aggressive type of brain tumor, usually undergo surgery to remove the tumor. However, it’s difficult for surgeons to remove all of the cancer cells, and the tumor often recurs.

MIT researchers have now designed an implantable drug-delivery device that they hope could help prevent recurrence of glioblastoma. Their device contains a reservoir that can release drugs over an extended period, along with ultrasound transducers that use sound waves to help drugs spread farther through the brain and bypass the blood-brain barrier.

Such a device could be implanted in the brain during surgery, then gradually release drugs that would help kill the remaining tumor cells. After implantation, a wireless controller can be used to program the exact ultrasound dosages to be delivered, enhancing the reach of the delivered therapy.